Chugai Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
27.87 | 46.22 | -39.71% | 14.1 | +97.7% |
| P/S |
|
9.22 | 4.38 | 110.41% |
|
|
| P/BV |
|
5.68 | 5.41 | 5.01% |
|
|
| P/FCF |
|
0.1676 | 26.95 | -99.38% |
|
|
| Ev/Ebitda |
|
18.92 | 17.44 | 8.47% |
|
|
| Ev/S |
|
8.76 | 4.5 | 94.65% |
|
|
| Ev/FCF |
|
26.11 | 39.19 | -33.38% |
|
|
| E/P |
|
5.89 | 1.06 | 454.53% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
46.3 | 23.21 | 99.48% | 43.82 | +5.67% |
| ROE |
|
21.96 | 14.54 | 51.06% |
|
|
| ROA |
|
18.71 | 7.4 | 152.88% |
|
|
| ROIC |
|
0 | 14.06 | -100% |
|
|
| ROS |
|
33.09 | 11.1 | 198.08% |
|
|
| ROCE |
|
21.86 | 17.57 | 24.45% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0248 | 2.91 | -99.15% | 0.0277 | -10.25% |
| Nеt Debt/Ebitda |
|
-0.9967 | 0.0376 | -2752.86% |
|
|
| Debt/Ratio |
|
0.0061 | 0.2175 | -97.2% |
|
|
| Debt/Equity |
|
0.1614 | 1.1 | -85.36% |
|
|
| Debt/Net Income |
|
0.0347 | 9 | -99.61% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
7.3/10
|
2.92 | 1.7 | 72.14% | 64.15 | -95.45% |
| Number of years of dividend growth |
|
3 | 1.85 | 62.04% | ||
| DSI |
|
0.9286 | 0.7795 | 19.12% |
|
|
| Average dividend growth |
|
-421.83 | -359.57 | 17.31% |
|
|
| Average percentage for 5 years |
|
64.15 | 3.31 | 1836.71% |
|
|
| Average percentage for payments |
|
41.43 | 151.74 | -72.69% |
|
|
| Difference from average difference in sector |
|
1.22 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
48.75 | 356.39 | -86.32% | ||
| Growth impulse Ebitda in 5 years |
|
81.73 | 337.43 | -75.78% | ||
| Growth impulse Net Income in 5 years |
|
80.37 | 247.92 | -67.58% | ||
| Growth impulse FCF in 5 years |
|
173.42 | 229.5 | -24.44% | ||
| Growth impulse EPS in 5 years |
|
80.13 | 436.02 | -81.62% |
IP Score
7.5/10
